Published in Medical Letter on the CDC and FDA, June 28th, 1999
Experts say that if the LYMErix vaccine (SmithKline Beecham Pharmaceuticals) is going to be successful anywhere, Connecticut ought to be the place. Connecticut has the highest rate of the disease in the country - 105 cases per 100,000 people in 1998.
But five months after the vaccine came on the market, local doctors say people are not exactly lining up for injections.
"I've lived here for years and years, and I think you'll find that most people who've lived here for years aren't that excited about it," said Lyme First...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA